Miles White, the longtime CEO of Abbott Laboratories will step down as chief executive in March 2020, according to The Wall Street Journal.

Teva Pharmaceuticals will resume producing the vital cancer drug vincristine after a shortage caused a "nightmare situation" for physicians and patients, according to STAT. 

Researchers are warning of a possible prolonged shortage of the vital blood-thinning drug heparin, which is made from pig intestines, as African Swine Fever is wiping out a quarter of the world's pigs, according to Bloomberg. 

Flint, Mich.-based Diplomat Pharmacy said it has "substantial doubt" it can stay in business as it reported significant net losses Nov. 12.

The number of product recalls in the U.S. remained steady from the second to third quarter, but will likely increase as regulators begin to focus on currently unregulated or underregulated areas, according to a report released Nov. 12. 

The Drug Enforcement Administration is suing the Colorado State Board of Pharmacy, demanding it share patient information from its prescription drug monitoring program, according to The Colorado Sun.

For a successful mergers and acquisition strategy, healthcare administrators need to ensure that integration plans fully leverage culture and change management principles – including standardizing best practices for the newly acquired organizations.

Hospital administrators face ever-shifting and increasing demands as they work to ensure that patients receive high-quality care, while also reigning in costs. Many hospitals today look to mergers and acquisitions as a strategy to help tackle these demands. In fact,…

In an unusual twist, the FDA revoked orphan status for Sublocade, an opioid addiction treatment manufactured by Indivior that was approved two years ago, according to STAT. 

American Health Packaging is the latest company to recall a ranitidine product after discovering it produces a possible carcinogen.